Press Releases

Perrigo is a leading global consumer-focused self-care company. Our vision is to make lives better by bringing “Quality, Affordable Self-Care Products” that consumers trust everywhere they are sold. The Company is a leading provider of health and wellness solutions that enhance individual well-being by empowering consumers to proactively prevent or treat conditions that can be self-managed.

Learn More

Perrigo Company to Present at UBS Warburg Global Specialty Pharmaceuticals Conference
PRNewswire
ALLEGAN, Mich.

The Perrigo Company (NASDAQ: PRGO) today announced that its presentation scheduled for Wednesday, May 23, 2001 at 8 a.m. EDT at the UBS Warburg Global Specialty Pharmaceuticals Conference in New York may be accessed via telephone conference call. The call-in numbers for the listen-only dial-in are 719-457-2605 and 888-515-2781. The call-in numbers for the recorded line are 402-220-8537 and 800-759-8603. The recorded line will be available for up to four weeks after the conference.

The slides used at the conference will be available on Perrigo's website at http://www.perrigo.com/investor prior to the presentation.

Perrigo Company is the nation's largest manufacturer of over-the-counter (nonprescription) pharmaceutical and nutritional products for the store brand market. Store brand products are sold by national and regional supermarket, drugstore and mass merchandise chains under their own labels and compete with nationally advertised brands. The Company's products include over-the-counter pharmaceuticals, such as analgesics, cough and cold remedies, antacids, laxatives, feminine hygiene and smoking cessation products, and nutritional products, such as vitamins, nutritional supplements and nutritional drinks. Visit Perrigo on the Internet at http://www.perrigo.com/ .

MAKE YOUR OPINION COUNT - Click Here
http://tbutton.prnewswire.com/prn/11690X34175702

SOURCE: Perrigo Company

Contact: Ernest J. Schenk, Manager, Investor Relations and
Communications of Perrigo Company, 616-673-9212, or E-mail:
investor@perrigo.com

Website: http://www.perrigo.com/

Company News On-Call: http://www.prnewswire.com/comp/699550.html or fax,
800-758-5804, ext. 699550